ANIK
Anika Therapeutics Inc
20.20$
-0.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.8% | 38.7% | 39.2% | 33.3% | 96.3% | – | 43.9% | 49.1% | 44.0% | 37.4% | 35.8% | 34.9% | 37.8% | |
| 60.2% | 61.3% | 60.8% | 66.7% | 3.7% | – | 56.1% | 50.9% | 56.0% | 62.6% | 64.2% | 65.1% | 62.2% | |
| 18.8% | 17.7% | 20.1% | 21.7% | 18.7% | – | 23.2% | 22.4% | 25.0% | 21.1% | 22.7% | 22.5% | 22.8% | |
| 59.9% | 47.3% | 53.1% | 64.5% | 49.3% | – | 49.3% | 43.3% | 42.7% | 39.5% | 60.0% | 33.6% | 43.7% | |
| 78.7% | 209.7% | 73.3% | 72.6% | 76.0% | – | 72.5% | 65.7% | 67.6% | 60.5% | 82.7% | 56.1% | 66.4% | |
| -18.5% | -148.4% | -12.5% | -5.9% | -72.3% | – | -16.4% | -14.8% | -11.6% | 2.1% | -18.5% | 9.1% | -4.2% | |
| – | 2.8% | 1.5% | – | – | – | 1.6% | 2.2% | 4.4% | 0.4% | 2.3% | – | – | |
| -17.0% | -147.1% | -11.0% | -4.0% | -71.2% | – | -14.8% | -14.1% | -8.0% | 2.5% | -16.3% | 10.4% | -2.4% | |
| -1.1% | -0.5% | 0.1% | 4.3% | 6.0% | – | 0.3% | 2.4% | 3.4% | -3.4% | 0.8% | 0.2% | 0.2% | |
| -15.9% | -146.6% | -11.1% | -0.3% | -77.2% | – | -18.6% | -14.1% | -8.4% | 1.0% | -17.1% | 10.1% | -3.1% | |
| -8.4% | 4.6% | -4.6% | 2.7% | -65.6% | – | -8.7% | -8.7% | -3.0% | 6.8% | -11.5% | 15.0% | 2.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.